Please wait a minute...
文章检索
预防医学  2020, Vol. 32 Issue (8): 757-761    DOI: 10.19485/j.cnki.issn2096-5087.2020.08.001
  论著 本期目录 | 过刊浏览 | 高级检索 |
2013—2018年杭州市HIV/AIDS病例检测发现与晚发现影响因素研究
罗艳, 赵刚, 黄思超, 罗文杰, 李西婷, 丁建明
杭州市疾病预防控制中心艾滋病性病防治所,浙江 杭州 310021
HIV/AIDS case detection and influencing factors for late diagnosisin Hangzhou from 2013 to 2018
LUO Yan, ZHAO Gang, HUANG Sichao, LUO Wenjie, LI Xiting, DING Jianming
Department of AIDS and STDs Prevention and Control, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang 310021, China
全文: PDF(856 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2013—2018年杭州市艾滋病病毒感染者和艾滋病患者(HIV/AIDS)检测发现与晚发现情况,并分析影响因素,为提高HIV抗体检测发现能力提供依据。方法 通过中国疾病预防控制信息系统艾滋病综合防治信息系统收集2013—2018年杭州市HIV抗体检测和新确证HIV/AIDS病例资料,分析不同地区、检测途径、检测机构和重点人群的HIV抗体检测人数和确证阳性情况;采用多因素Logistic回归模型分析新确证HIV/AIDS病例晚发现的影响因素。结果 2013—2018年杭州市HIV抗体检测率、阳性率和晚发现比例均呈上升趋势,年均检测率为24.99%,阳性率为6.95/万,晚发现比例为30.07%。多因素Logistic回归分析结果显示,年龄≥20岁(OR:1.912~5.117,95%CI:1.250~7.904)和男性(OR=1.656,95%CI:1.351~2.030)的晚发现风险较高;受血(制品)前检测(OR=4.429,95%CI:2.217~9.225)、其他就诊者检测(OR=2.137,95%CI:1.615~2.826)、术前检测(OR=2.137,95%CI:1.615~2.826)、性病门诊检测(OR=1.359,95%CI:1.007~1.834)较自愿咨询检测的晚发现风险高;疾控中心(OR=0.714,95%CI:0.558~0.915)和社区卫生服务中心(OR=0.645,95%CI:0.441~0.943)较医疗机构检测的晚发现风险低;经异性性接触感染者较经同性性接触感染者的晚发现风险高(OR=1.299,95%CI:1.130~1.493);有性病史者较无性病史者的晚发现风险低(OR=0.818,95%CI:0.706~0.948)。结论 2013—2018年杭州市HIV抗体检测发现力度扩大,但HIV/AIDS病例晚发现比例呈上升趋势;年龄、性别、检测途径和机构、感染途径及性病史是HIV/AIDS病例晚发现的影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
罗艳
赵刚
黄思超
罗文杰
李西婷
丁建明
关键词 艾滋病HIV抗体检测晚发现    
AbstractObjective To analyze current situation of HIV/AIDS case detection and factors associated with late diagnosis among the newly diagnosed cases from 2013 to 2018 in Hangzhou, so as to provide basis for improving the detection capacity of HIV. Methods The data of HIV testing and newly diagnosed HIV/AIDS cases in Hangzhou from 2013 to 2018 were collected through the China AIDS Prevention and Control Information System. The proportion of HIV antibody detection and positive cases in different regions, detection ways and high-risk groups were analyzed. The influencing factors for late diagnosis were analyzed by multivariate logistic regression model. Results The proportions of cases with HIV detected, HIV positive and late diagnosis increased from 2013 to 2018, and the annual ones were 24.99%, 6.95 per ten thousand and 30.07%, respectively. The results of the multivariate logistic regression analysis showed that people who were male ( OR=1.656, 95%CI: 1.351-2.030 ) and aged older ( OR: 1.912-5.117, 95%CI: 1.250-7.904 ) had higher risks of late diagnosis; who detected HIV through pre-test of receiving blood ( OR=4.429, 95%CI:2.217-9.225 ) , other inpatient detection ( OR=2.137, 95%CI: 1.615-2.826 ) , preoperative testing ( OR=2.137, 95%CI: 1.615-2.826 ) and testing of STD clinic attendants ( OR=1.359, 95%CI: 1.007-1.834 ) had higher risks of late diagnosis compared to those diagnosed at VCT clinics; who diagnosed at CDCs ( OR=0.714,95%CI: 0.558-0.915 ) and community health centers ( OR=0.645, 95%CI: 0.441-0.943 ) had lower risks of late diagnosis than those diagnosed in hospitals; who were infected by heterosexual contact ( OR=1.299, 95%CI: 1.130-1.493 ) had a higher risk of late diagnosis than MSM; who had history of STD ( OR=0.818, 95%CI: 0.706-0.948 ) had a lower risk of late diagnosis than who did not.Conclusions HIV testing and case detection had been expanded, but late diagnosis had not been improved in Hangzhou from 2013 to 2018. Age, sex, route and institution of diagnosis, transmission route and history of STD were influencing factors of late diagnosis.
Key wordsacquired immune deficiency syndrome    HIV antibody    detection    late diagnosis
收稿日期: 2020-02-22      出版日期: 2020-08-14
ZTFLH:  R512.91  
基金资助:浙江省医药卫生科技计划项目(2020KY777,2018KY638,2015KYA189;杭州市科技局社会发展项目(20160533B51,20191203B140);杭州市卫生计生科技计划A类项目(2018A81)
通信作者: 罗艳,E-mail:64441399@qq.com   
作者简介: 罗艳,硕士,副主任医师,主要从事艾滋病性病防制工作
引用本文:   
罗艳, 赵刚, 黄思超, 罗文杰, 李西婷, 丁建明. 2013—2018年杭州市HIV/AIDS病例检测发现与晚发现影响因素研究[J]. 预防医学, 2020, 32(8): 757-761.
LUO Yan, ZHAO Gang, HUANG Sichao, LUO Wenjie, LI Xiting, DING Jianming. HIV/AIDS case detection and influencing factors for late diagnosisin Hangzhou from 2013 to 2018. Preventive Medicine, 2020, 32(8): 757-761.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2020.08.001      或      http://www.zjyfyxzz.com/CN/Y2020/V32/I8/757
[1] ZHAO Y,HAN M J,MA Y,et al.Progress towards the 90-90-90 targets for controlling HIV—China,2018[J].CCDC Weekly,2019,1(1):5-7.
[2] TANG H L,MAO Y R,SHI C X,et al.Baseline CD4 cell counts of newly diagnosed HIV cases in China:2006-2012[J/OL].PLoS One,2014,9(6)[2020-05-18].https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0096098.
[3] VALDISERRI R O.Late HIV diagnosis:bad medicine and worse public health[J].PLoS Med,2007,4(6):875-976.
[4] BISSET L R,CONE R W,HUBER W,et al.Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities,Swiss HIV Cohort Study[J].AIDS,1998,12(16):2115-2123.
[5] 袁月荣,唐倩如,陈冰冰,等.海曙区新报告HIV/AIDS病例晚发现情况分析[J].预防医学,2018,30(11):1136-1141.
[6] MORENO S,MOCROFT A,MONFORTE A.Medical and societal consequences of late presentation[J].Antivir Ther,2010,15(1):9-15.
[7] CHKHARTISHVILI N,CHOKOSHVILI O,BOLOKADZE N,et al.Late presentation of HIV infection in the country of Georgia:2012-2015[J/OL].PLoS One,2017,12(10)[2020-05-18].https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186835.
[8] DELPIERRE C,DRAY-SPIRA R,CUZIN L,et al.Correlates of late HIV diagnosis:implications for testing policy[J].Int J STD AIDS,2007,18(5):312-317.
[9] 金霞,熊燃,王丽艳,等.2010—2014年我国HIV感染病例的晚发现情况分析[J].中华流行病学杂志,2016,37(2):218-221.
[10] 周崇兴,胡茜,沈智勇,等.2015年广西壮族自治区新报告HIV感染者/AIDS患者晚发现的影响因素[J].中华疾病控制杂志,2017,21(9):888-899.
[11] 葛锐,张倩倩,徐文贤,等.2011—2016年嘉兴市新报告HIV/AIDS病人的晚发现情况分析[J].中国艾滋病性病,2017,23(11):1078-1079.
[12] 何冰. 江山市HIV/AIDS晚发现情况分析[J].预防医学,2016,28(12):1259-1261.
[13] REIF L K,RIVERA V,LOUIS B,et al.Community-based HIV and health testing for high-risk adolescents and youth[J].AIDS Patient Care STDS,2016,30(8):371-378.
[14] HE X,FENG X,LIU P,et al.An innovative vending machine-based HIV testing and intervention service in China:anonymous urine collection kits distributed at universities[J].AIDS Care,2019,31(22):1-4.
[15] HU X,LIANG B Y,ZHOU C X,et al.HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China:a large-scale cross-sectional study[J/OL].AIDS Res Ther,2019,16(1)[2020-05-18].https:// aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-019-0221-7.
[16] 潘晓红,陈琳,徐云,等.2012年浙江省HIV感染者和艾滋病患者检测发现特征及影响因素[J].中华预防医学杂志,2014,48(5):380-385.
[17] CELESIA B M,CASTRONUOVO D,PINZONE M R,et al.Late presentation of HIV infection:predictors of delayed diagnosis and survival in Eastern Sicily[J].Eur Rev Med Pharmacol Sci,2013,17(16):2218-2224.
[18] DRAIN P K,LOSINA E,PARKER G,et al.Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban,South Africa[J/OL].PLoS One,2013,8(1)[2020-05-18].https://pubmed.ncbi.nlm.nih.gov/23383147.
[19] KIGOZI I M,DOBKIN L M,MARTIN J N,et al.Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa[J].J Acquir Immune Defic Syndr,2009,52(2):280-289.
[1] 张宏, 陈剑惠, 刘梅艳, 何鼎盛. 2011—2019年福州市经性接触传播的男性HIV/AIDS病例特征[J]. 预防医学, 2020, 32(9): 907-910.
[2] 蒋均, 罗明宇, 杨介者, 何林, 徐云, 周欣. 2015—2019年浙江省新确证50岁及以上HIV/AIDS病例流行特征分析[J]. 预防医学, 2020, 32(8): 762-766.
[3] 王瑞, 张海兰, 黄晓丹, 卫晓丽. 西安市性病门诊男性就诊者艾滋病和性病监测结果[J]. 预防医学, 2020, 32(8): 813-816.
[4] 丁坚强, 项琼珊, 陈婉君, 刘巨敏. 镇海区性病患者HIV抗体检测及影响因素分析[J]. 预防医学, 2020, 32(6): 618-620.
[5] 任鸿, 王鹏, 曹艺耀, 张美辨, 宣志强, 邹华, 俞顺飞, 周振. 浙江省职业卫生检测能力实验室间比对结果分析[J]. 预防医学, 2020, 32(6): 641-643.
[6] 王斌, 龚德光, 朱洁群. 鄞州区艾滋病抗病毒治疗患者生存率及影响因素分析[J]. 预防医学, 2020, 32(4): 346-350.
[7] 唐慧玲, 蒋均, 罗明宇, 金屡华, 王凤英, 潘晓红. 金华市2017年新确诊性接触传播HIV/AIDS本地感染病例特征及影响因素分析[J]. 预防医学, 2020, 32(4): 355-360.
[8] 张友春,汪睿 综述,朱永良 审校. 新型冠状病毒实验室检测方法研究进展[J]. 预防医学, 2020, 32(4): 361-365.
[9] 张兴亮, 罗艳, 丁建明, 吴虹, 蒋均. 2017年杭州市新确诊男男性行为人群HIV/AIDS病例特征分析[J]. 预防医学, 2020, 32(4): 373-377.
[10] 卢江炜, 汤雪娟. 嘉兴市HIV感染孕产妇特征及艾滋病母婴阻断分析[J]. 预防医学, 2020, 32(4): 405-407.
[11] 陈卫永, 潘晓红, 杨介者, 蒋均, 姜婷婷, 陈琳, 陈婉君, 王憓, 周欣, 马瞧勤. 浙江省第三轮艾滋病综合防治示范区评估结果[J]. 预防医学, 2020, 32(3): 240-244.
[12] 邓小芳, 岑平, 唐驰, 徐红, 林倩, 农丽萍, 钟永泉, 李斯斯, 姚敏. 南宁市新报告HIV/AIDS病例CD4+T淋巴细胞首次检测结果分析[J]. 预防医学, 2020, 32(3): 270-273.
[13] 赵晨飞, 朱明利, 师金川, 喻剑华. 艾滋病抗病毒治疗对HIV-1感染者肠道微生态的影响[J]. 预防医学, 2020, 32(3): 274-278.
[14] 艾克丹·塔西, 马媛媛, 胡晓远, 倪祯, 倪明健. 乌鲁木齐市男男性行为人群HIV新发感染及影响因素分析[J]. 预防医学, 2020, 32(3): 278-281.
[15] 徐雪琴, 方凤梅. 农村地区两种宫颈癌筛查方案应用效果比较[J]. 预防医学, 2020, 32(3): 315-317.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed